Andrew Fellows Quotes

The gross margin expansion is really coming through from switch from urinary to recombinant products. It bodes well for 2001. - Andrew Fellows

In as much as they don't have that many launches coming through at the moment, they can afford to ease up a bit on the marketing spend. - Andrew Fellows

If the U.S. order is as big as rumored, the sales will be recorded over 2005/2006, and possibly into 2007 depending on how much product Roche can deliver. - Andrew Fellows

Page 1 of 1